Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer
P Bigot, P Barthelemy, R Boissier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2018
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
L Derosa, M D Hellmann, M Spaziano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2015
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)
M De Santis, P J Wiechno, J Bellmunt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 15, 2021
Severe COVID-19 in patients with hematological cancers presenting with viremia
J M Michot, T Hueso, N Ibrahimi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 19, 2024
Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d'Étude des Tumeurs Uro-Génitales) study
F Carneiro, A Vinceneux, M Larroquette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2025
Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinoma
B I Rini, L Albiges, X Tang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2021
Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?
A Laparra, M Kfoury, S Champiat, et al.
British Journal of Cancer
|
November 4, 2015
RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs
B Beuselinck, J Jean-Baptiste, G Couchy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2014
PD-L1 expression in nonclear-cell renal cell carcinoma
T K Choueiri, A P Fay, K P Gray, et al.
ESMO Open
|
September 3, 2021
Erratum to 'Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101]
T K Choueiri, J Larkin, S Pal, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer
P Bigot, P Barthelemy, R Boissier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2018
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
L Derosa, M D Hellmann, M Spaziano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2015
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)
M De Santis, P J Wiechno, J Bellmunt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 15, 2021
Severe COVID-19 in patients with hematological cancers presenting with viremia
J M Michot, T Hueso, N Ibrahimi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 19, 2024
Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d'Étude des Tumeurs Uro-Génitales) study
F Carneiro, A Vinceneux, M Larroquette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2025
Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinoma
B I Rini, L Albiges, X Tang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2021
Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?
A Laparra, M Kfoury, S Champiat, et al.
British Journal of Cancer
|
November 4, 2015
RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs
B Beuselinck, J Jean-Baptiste, G Couchy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2014
PD-L1 expression in nonclear-cell renal cell carcinoma
T K Choueiri, A P Fay, K P Gray, et al.
ESMO Open
|
September 3, 2021
Erratum to 'Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101]
T K Choueiri, J Larkin, S Pal, et al.
Page
of 7